Correlation Between Gilead Sciences and Bionano Genomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and Bionano Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and Bionano Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and Bionano Genomics, you can compare the effects of market volatilities on Gilead Sciences and Bionano Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of Bionano Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and Bionano Genomics.

Diversification Opportunities for Gilead Sciences and Bionano Genomics

-0.84
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Gilead and Bionano is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and Bionano Genomics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionano Genomics and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with Bionano Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionano Genomics has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and Bionano Genomics go up and down completely randomly.

Pair Corralation between Gilead Sciences and Bionano Genomics

Given the investment horizon of 90 days Gilead Sciences is expected to generate 0.36 times more return on investment than Bionano Genomics. However, Gilead Sciences is 2.8 times less risky than Bionano Genomics. It trades about 0.11 of its potential returns per unit of risk. Bionano Genomics is currently generating about -0.06 per unit of risk. If you would invest  8,882  in Gilead Sciences on September 1, 2024 and sell it today you would earn a total of  376.00  from holding Gilead Sciences or generate 4.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Gilead Sciences  vs.  Bionano Genomics

 Performance 
       Timeline  
Gilead Sciences 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Gilead Sciences are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak essential indicators, Gilead Sciences exhibited solid returns over the last few months and may actually be approaching a breakup point.
Bionano Genomics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bionano Genomics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Gilead Sciences and Bionano Genomics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Gilead Sciences and Bionano Genomics

The main advantage of trading using opposite Gilead Sciences and Bionano Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, Bionano Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionano Genomics will offset losses from the drop in Bionano Genomics' long position.
The idea behind Gilead Sciences and Bionano Genomics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Fundamental Analysis
View fundamental data based on most recent published financial statements
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.